Literature DB >> 1683671

Comparison of cytolytic and proliferative activities of human gamma delta and alpha beta T cells from peripheral blood against various human tumor cell lines.

A S Ensslin1, B Formby.   

Abstract

Peripheral blood lymphocytes (PBLs) from healthy donors were more than 95% enriched for gamma delta T cells. V gamma 9/V delta 2 was the predominant T-cell subset and represented more than two thirds of the isolated gamma delta T cells. When activated by surface-immobilized anti-TCR delta 1 monoclonal antibody (MoAb) during 5 days of culture, gamma delta T cells demonstrated a significant fourfold to 15-fold stronger cytolytic activity against various tumor cell lines than did PBL polyclonal alpha beta T cells analogously activated by surface-immobilized anti-CD3 MoAbs. Blocking experiments with specific MoAbs demonstrated that the cytolytic activity of gamma delta T cells was non-major histocompatibility complex (MHC) restricted and did not involve the gamma delta T-cell antigen receptor (TCR) but that cytolytic activity was dependent on LFA-1 beta/ICAM1 interaction. The proliferative responses of gamma delta and alpha beta T cells to Ovcar-3 tumor cells and irradiated allogeneic PBLs were inhibited by anti-HLA-A,B,C MoAb. Our findings suggest that gamma delta T cells activated via the TCR have a significant advantage in non-MHC-restricted lysis of various tumor cell lines over PBL alpha beta T cells stimulated analogously with anti-CD3, which may be important in terms of applicability of activated gamma delta cells for adoptive immunotherapy of metastatic cancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683671     DOI: 10.1093/jnci/83.21.1564

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.

Authors:  Aneta Zysk; Mark O DeNichilo; Vasilios Panagopoulos; Irene Zinonos; Vasilios Liapis; Shelley Hay; Wendy Ingman; Vladimir Ponomarev; Gerald Atkins; David Findlay; Andrew Zannettino; Andreas Evdokiou
Journal:  Cancer Lett       Date:  2016-11-16       Impact factor: 8.679

2.  Sendai virus pneumonia: evidence for the early recruitment of gamma delta T cells during the disease course.

Authors:  T Ogasawara; M Emoto; K Kiyotani; K Shimokata; T Yoshida; Y Nagai; Y Yoshikai
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 3.  Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells.

Authors:  Elizabeth M Urban; Andrei I Chapoval; C David Pauza
Journal:  Clin Dev Immunol       Date:  2010-04-13

4.  Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model.

Authors:  Nicholas A Zumwalde; Akshat Sharma; Xuequn Xu; Shidong Ma; Christine L Schneider; James C Romero-Masters; Amy W Hudson; Annette Gendron-Fitzpatrick; Shannon C Kenney; Jenny E Gumperz
Journal:  JCI Insight       Date:  2017-07-06

5.  Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.

Authors:  Gabrielle M Siegers; Tania C Felizardo; A Mark Mathieson; Yoko Kosaka; Xing-Hua Wang; Jeffrey A Medin; Armand Keating
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

6.  Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.

Authors:  A J Nicol; H Tokuyama; S R Mattarollo; T Hagi; K Suzuki; K Yokokawa; M Nieda
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

7.  Anti-leukemia activity of human gamma delta T cells.

Authors:  Gabrielle M Siegers
Journal:  Oncoimmunology       Date:  2012-03-01       Impact factor: 8.110

8.  Expansion and Adoptive Transfer of Human Vδ2+ T Cells to Assess Antitumor Effects In Vivo.

Authors:  Akshat Sharma; Nicholas A Zumwalde; Jenny E Gumperz
Journal:  Methods Mol Biol       Date:  2019

9.  Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells.

Authors:  Martine J Kallemeijn; Anne Mieke H Boots; Michèle Y van der Klift; Elisabeth Brouwer; Wayel H Abdulahad; Jan A N Verhaar; Jacques J M van Dongen; Anton W Langerak
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

10.  A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

Authors:  S M Behar; S A Porcelli; E M Beckman; M B Brenner
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.